These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7225603)

  • 1. Prognostic classification and choice of treatment in operated breast cancers. Contribution of an (AID 3) multivariate analysis.
    Bonichon F; Durand M; Avril A; Dilhuydy MH; Lagarde C
    Bull Cancer; 1980; 67(4):470-6. PubMed ID: 7225603
    [No Abstract]   [Full Text] [Related]  

  • 2. Castration as part of the primary treatment for operable female breast cancer. A statistical evaluation of clinical results.
    Nissen-Meyer R
    Acta Radiol Diagn (Stockh); 1965; ():Suppl 249:1+. PubMed ID: 5867959
    [No Abstract]   [Full Text] [Related]  

  • 3. Prediction of lymph node status by analysis of prognostic factors and possible indications for elective axillary dissection in T1 breast cancers.
    Guarnieri A; Neri A; Correale PP; Lottini M; Testa M; Mariani F; Tucci E; Megha T; Cintorino M; Carli A
    Eur J Surg; 2001 Apr; 167(4):255-9. PubMed ID: 11354316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytometric prognostic parameters in breast cancer.
    Aubele M; Auer G; Höfler
    Anticancer Res; 1996; 16(5B):3085-7. PubMed ID: 8920772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the prognostic effects of inclusion in a clinical trial and of myelosuppression on survival after adjuvant chemotherapy for breast carcinoma.
    Mayers C; Panzarella T; Tannock IF
    Cancer; 2001 Jun; 91(12):2246-57. PubMed ID: 11413512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.
    Brouckaert O; Pintens S; Van Belle V; Van Huffel S; Camerlynck E; Amant F; Leunen K; Smeets A; Berteloot P; Van Limbergen E; Decock J; Hendrickx W; Weltens C; Van den Bogaert W; Vanden Bempt I; Drijkoningen M; Paridaens R; Wildiers H; Vergote I; Christiaens MR; Neven P
    Breast Cancer Res Treat; 2009 May; 115(2):349-58. PubMed ID: 18629635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up.
    Evans AJ; Rakha EA; Pinder SE; Green AR; Paish C; Ellis IO
    J Med Screen; 2007; 14(4):210-4. PubMed ID: 18078567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and prognosis of primary breast cancer.
    Robertson JF; Evans AJ
    Q J Nucl Med; 1997 Sep; 41(3):200-10. PubMed ID: 9274128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic studies in cancer of the breast: optimal use of current statistical tools].
    Bonichon F
    Bull Cancer; 1996 Dec; 83(12):1046-52. PubMed ID: 9116374
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidermal growth factor receptor status in operable invasive breast cancer: is it of any prognostic value?
    Rampaul RS; Pinder SE; Wencyk PM; Nicholson RI; Blamey RW; Robertson JF; Ellis IO
    Clin Cancer Res; 2004 Apr; 10(7):2578. PubMed ID: 15073139
    [No Abstract]   [Full Text] [Related]  

  • 11. [Intraductal papillomas of the breast--clinico-morphological review and analysis [corrected] of 23 cases].
    Akush Ginekol (Sofiia); 2008; 47(6):25-7. PubMed ID: 19227784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of mammographic detection in a cohort of conservatively treated breast cancer patients.
    Haffty BG; Lee C; Philpotts L; Horvath L; Ward B; McKhann C; Tocino I
    Cancer J Sci Am; 1998; 4(1):35-40. PubMed ID: 9467044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of definition of receptor status in the prognosis and the choice of adequate treatment tactics of breast tumors].
    Abuladze TZ; Nemsadze GG; Gersamiia GK
    Georgian Med News; 2006 Aug; (137):22-4. PubMed ID: 16980736
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prognostic factors in operated breast carcinoma].
    Bianco V; De Benedetto A; Simeoni F; Toto A; Paris E; Chiodini S; Marchei P
    Minerva Med; 1995; 86(1-2):17-20. PubMed ID: 7753433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic molecular classification of breast cancers based on gene expression profiling].
    Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a three-gene expression signature of poor-prognosis breast carcinoma.
    Bièche I; Tozlu S; Girault I; Lidereau R
    Mol Cancer; 2004 Dec; 3(1):37. PubMed ID: 15606925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic importance of palpability as a feature of screen-detected breast cancers.
    Gill G; Luke C; Roder D
    J Med Screen; 2006; 13(2):98-101. PubMed ID: 16792834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The time-related changes of the importance of prognostic factors in breast cancer. A sequential multivariate analysis of 1423 Japanese patients.
    Takeuchi H; Baba H; Kano T; Maehara Y
    Breast Cancer Res Treat; 2005 Dec; 94(3):273-8. PubMed ID: 16261405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer.
    Neri A; Marrelli D; Roviello F; DeMarco G; Mariani F; DeStefano A; Megha T; Caruso S; Corso G; Cioppa T; Pinto E
    Breast Cancer Res Treat; 2006 Sep; 99(1):77-83. PubMed ID: 16541314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic tissue criteria of pT1-2, pN0-1, M0 cancers of the breast with a low or moderate metastatic potential].
    Bolla M; Pasquier D; Chédin M; Winckel P; Mousseau M; Berland E; Salvat J; Panh MH; Payan R
    Bull Cancer; 1996 Dec; 83(12):1061. PubMed ID: 9116376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.